BUSSOLINO, Federico
 Distribuzione geografica
Continente #
NA - Nord America 12.310
EU - Europa 9.349
AS - Asia 4.941
AF - Africa 76
SA - Sud America 28
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.736
Nazione #
US - Stati Uniti d'America 12.075
CN - Cina 2.781
IT - Italia 1.486
IE - Irlanda 1.254
UA - Ucraina 1.145
SE - Svezia 1.122
DE - Germania 1.088
FR - Francia 903
SG - Singapore 836
FI - Finlandia 714
KR - Corea 611
GB - Regno Unito 594
PL - Polonia 336
CA - Canada 223
VN - Vietnam 205
AT - Austria 180
DK - Danimarca 149
JP - Giappone 118
RU - Federazione Russa 93
BE - Belgio 83
ID - Indonesia 77
IN - India 75
NL - Olanda 63
HK - Hong Kong 60
SN - Senegal 60
TW - Taiwan 42
TR - Turchia 34
IR - Iran 26
CH - Svizzera 23
GR - Grecia 22
NO - Norvegia 21
SA - Arabia Saudita 19
AU - Australia 18
ES - Italia 16
BR - Brasile 13
UZ - Uzbekistan 13
MX - Messico 12
RO - Romania 12
PH - Filippine 9
TH - Thailandia 9
CL - Cile 8
BY - Bielorussia 7
EU - Europa 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
IQ - Iraq 6
ZA - Sudafrica 6
RS - Serbia 5
AL - Albania 4
CZ - Repubblica Ceca 4
IL - Israele 4
AR - Argentina 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
MY - Malesia 3
NG - Nigeria 3
BG - Bulgaria 2
HR - Croazia 2
LK - Sri Lanka 2
LT - Lituania 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
PE - Perù 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
GE - Georgia 1
IS - Islanda 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 26.736
Città #
Beijing 1.884
Chandler 1.789
Dublin 1.250
Ann Arbor 804
Jacksonville 734
Houston 640
Singapore 608
Villeurbanne 598
Fairfield 573
Ashburn 431
Medford 417
Torino 416
Princeton 410
Woodbridge 410
Dearborn 384
Nyköping 346
Wilmington 339
Warsaw 318
Milan 207
Seattle 204
Cambridge 198
Vienna 173
Boston 158
Boardman 140
Pisa 140
Fremont 138
Toronto 137
Dong Ket 116
Turin 112
Santa Clara 96
Guangzhou 93
Verona 84
Jakarta 76
Nanjing 74
Shanghai 70
Brussels 68
Falls Church 68
Norwalk 65
Redwood City 65
Hefei 60
San Mateo 53
Hangzhou 48
Lachine 48
Jinan 43
Kunming 43
New York 43
San Diego 38
Helsinki 35
Düsseldorf 31
Washington 31
Munich 30
Taipei 30
Wuhan 27
Padova 24
Rome 24
Hong Kong 23
Xian 23
Los Angeles 22
Monmouth Junction 20
Pune 20
Redmond 20
Amsterdam 19
Changsha 19
London 19
Fuzhou 18
Hebei 18
Mountain View 18
Saint Petersburg 18
Nanchang 17
Phoenix 17
Sanayi 17
Tokyo 17
Zhengzhou 17
Seoul 16
Chengdu 15
San Jose 15
Chicago 14
Dammam 14
Nuremberg 14
Piemonte 14
Upper Marlboro 14
Stavanger 13
Las Vegas 12
Shenyang 12
Tianjin 12
Bruehl 11
Tappahannock 11
Ardabil 10
Auburn Hills 10
Central District 10
Dallas 10
Florence 10
Bangkok 9
Chongqing 9
Detroit 9
Frankfurt am Main 9
Genoa 9
Ottawa 9
Silver Spring 9
São Paulo 9
Totale 16.092
Nome #
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 462
Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2 397
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 320
Semaphorins in cardiovascular medicine. 279
A transient kinetic study between signaling proteins: the case of the MEK–ERK interaction 274
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 255
CCL16 activates an angiogenic program in vascular endothelial cells 249
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 248
Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. 239
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 206
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer 203
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 191
A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2 176
A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis 174
Modulation of Angiopoietin 2 release from endothelial cells and angiogenesis by the synaptic protein Neuroligin 2 171
The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma which also offers prognostic value in patients 169
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 168
PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations 157
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 156
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 150
Real-time monitoring of cell protrusion dynamics by impedance responses 150
Differential regulation of neurexin at glutamatergic and GABAergic synapses. 147
TFEB controls vascular development by regulating the proliferation of endothelial cells 146
Simplification of a complex signal transduction model using invariants and flow equivalent servers 145
A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence 139
Fluorescence anisotropy analysis of protein-antibody interaction 136
Neuroligin 1 induces blood vessel maturation by cooperating with the α6 integrin. 134
Nervous vascular parallels: axon guidance and beyond 129
Consensus guidelines for the use and interpretation of angiogenesis assays 128
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. 126
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 125
A complex of α6 integrin and E-cadherin drives the liver metastasis of colorectal cancer cells by a physical and functional interaction with hepatic angiopoietin-like 6 125
Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 120
A computational model for eukaryotic directional sensing 115
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 115
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 112
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 110
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 110
Tumor progression: the neuronal input 110
Evidence for a role of the Na+/H+ exchanger in the colony-stimulating-factor-induced ornithine decarboxylase activity and proliferation of the human cell line M-07e. 109
A novel mechanism of HIV-1 entry into host cells and peptides inhibiting this mechanism 108
An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. 107
Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. 107
A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence 107
Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells 107
KRAS-driven metabolic rewiring reveals novel actionable targets in cancer 107
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. 106
Biological aspects of tumour angiogenesis 105
MicroRNA-mediated regulatory circuits: outlook and perspectives 105
Human GM-CSF in vivo: identification of the target cells and of their kinetics of response. 103
Human alpha-thrombin induces phosphoinositide turnover and Ca2+ movements in cultured human umbilical vein endothelial cells. 103
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro 103
Human endothelial cells are targets for platelet-activating factor (PAF).Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. 102
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 102
A new computational approach to analyze human protein complexes and predict novel protein interactions 101
Angiogenesis: prognostic significance in laryngeal cancer. 100
Vasculogenic potential of long term repopulating cord blood progenitors 100
Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1. 97
Role of Na+/H+ exchange in the granulocyte-macrophage colony-stimulating factor-dependent growth of a leukemic cell line M07e. 97
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy 97
On the use of stochastic Petri nets in the analysis of Signal Transduction Pathways for Angiogenesis process 97
Gene expression profiling of HMGB1-stimulated endothelial cells: a balancing act between angiogenesis and inflammation 95
Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis 95
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 93
Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma 92
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 91
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 90
Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere-associated protein CENP-F to kinetochores. 90
MRCKalpha is activated by caspase cleavage to assemble an apical actin ring for epithelial cell extrusion 89
Identification of CD36 molecular features required for its in vitro angiostatic activity. 88
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 88
The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling 88
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma 88
Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. 87
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. 86
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. 86
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. 85
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. 85
Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition 85
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms 85
SPAD aptasensor for the detection of circulating protein biomarkers 85
Recombinant AAV vector encoding human VEGF165 enhances wound healing. 84
A simulation environment for directional sensing as a phase separation process 84
Multifaceted activities of transcription factor eb in cancer onset and progression 84
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival 83
Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1 83
Besides adhesion: new perspectives of integrin functions in angiogenesis 83
Fluorescence anisotropy analysis of protein-antibody interaction 83
A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. 83
Unraveling the influence of endothelial cell density on VEGF-A signaling 83
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 82
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. 82
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. 82
Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. 81
Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. 81
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 81
Target cells for GM-CSF and kinetics of response. 80
Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. 80
Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 80
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. 80
Totale 12.666
Categoria #
all - tutte 86.677
article - articoli 0
book - libri 0
conference - conferenze 6.552
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.207 0 0 0 266 258 642 502 259 468 338 293 181
2020/20213.287 250 220 321 204 319 172 258 115 467 330 215 416
2021/20223.657 173 176 174 190 134 180 325 182 135 319 778 891
2022/20235.271 591 374 110 461 558 1.307 436 344 592 94 284 120
2023/20242.079 312 404 132 128 125 192 71 87 21 99 164 344
2024/20251.018 68 578 251 121 0 0 0 0 0 0 0 0
Totale 27.757